

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * detection of light stimulus (GO:0009583) | 9.86875049 |
| 2 | * detection of visible light (GO:0009584) | 9.76138057 |
| 3 | retinal rod cell development (GO:0046548) | 9.58682143 |
| 4 | sphingoid metabolic process (GO:0046519) | 9.54721639 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 9.05370841 |
| 6 | * visual perception (GO:0007601) | 8.69099680 |
| 7 | protein-chromophore linkage (GO:0018298) | 8.68790748 |
| 8 | * sensory perception of light stimulus (GO:0050953) | 8.59901909 |
| 9 | photoreceptor cell differentiation (GO:0046530) | 7.67075593 |
| 10 | eye photoreceptor cell differentiation (GO:0001754) | 7.67075593 |
| 11 | * cellular response to light stimulus (GO:0071482) | 7.26484824 |
| 12 | * detection of external stimulus (GO:0009581) | 6.87778323 |
| 13 | retina development in camera-type eye (GO:0060041) | 6.76809501 |
| 14 | * detection of abiotic stimulus (GO:0009582) | 6.76339435 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 6.76311620 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.76311620 |
| 17 | regulation of cGMP metabolic process (GO:0030823) | 6.49619528 |
| 18 | DNA methylation involved in gamete generation (GO:0043046) | 6.41383135 |
| 19 | regulation of meiosis I (GO:0060631) | 6.28469961 |
| 20 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.88422897 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 5.85661200 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.85661200 |
| 23 | lipopolysaccharide biosynthetic process (GO:0009103) | 5.80903054 |
| 24 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 5.70355197 |
| 25 | heme transport (GO:0015886) | 5.57918858 |
| 26 | regulation of cGMP biosynthetic process (GO:0030826) | 5.50948462 |
| 27 | sulfate transmembrane transport (GO:1902358) | 5.45635696 |
| 28 | regulation of protein glycosylation (GO:0060049) | 5.36703302 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 5.34532248 |
| 30 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 5.27973294 |
| 31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.23856069 |
| 32 | positive regulation of cGMP metabolic process (GO:0030825) | 5.17335092 |
| 33 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.11014152 |
| 34 | nonmotile primary cilium assembly (GO:0035058) | 5.09639111 |
| 35 | tyrosine metabolic process (GO:0006570) | 5.08489820 |
| 36 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.07592605 |
| 37 | lipopolysaccharide metabolic process (GO:0008653) | 4.99356569 |
| 38 | drug catabolic process (GO:0042737) | 4.94847363 |
| 39 | piRNA metabolic process (GO:0034587) | 4.93134111 |
| 40 | exogenous drug catabolic process (GO:0042738) | 4.89494830 |
| 41 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.80343026 |
| 42 | sulfate transport (GO:0008272) | 4.77001438 |
| 43 | * cellular response to radiation (GO:0071478) | 4.73709115 |
| 44 | adaptation of signaling pathway (GO:0023058) | 4.69358208 |
| 45 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.62416190 |
| 46 | flavonoid metabolic process (GO:0009812) | 4.58698529 |
| 47 | * regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.43459136 |
| 48 | regulation of pigment cell differentiation (GO:0050932) | 4.39945603 |
| 49 | positive regulation of developmental pigmentation (GO:0048087) | 4.29506947 |
| 50 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.25371244 |
| 51 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.24984442 |
| 52 | centriole replication (GO:0007099) | 4.20113169 |
| 53 | epoxygenase P450 pathway (GO:0019373) | 4.19838737 |
| 54 | * sensory perception (GO:0007600) | 4.18839578 |
| 55 | aromatic amino acid family metabolic process (GO:0009072) | 4.17509950 |
| 56 | retina layer formation (GO:0010842) | 4.15234046 |
| 57 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.13752076 |
| 58 | tryptophan catabolic process (GO:0006569) | 4.08506139 |
| 59 | indole-containing compound catabolic process (GO:0042436) | 4.08506139 |
| 60 | indolalkylamine catabolic process (GO:0046218) | 4.08506139 |
| 61 | omega-hydroxylase P450 pathway (GO:0097267) | 4.04069842 |
| 62 | drug metabolic process (GO:0017144) | 4.01241773 |
| 63 | protein prenylation (GO:0018342) | 3.99981029 |
| 64 | prenylation (GO:0097354) | 3.99981029 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 3.96928398 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.96035523 |
| 67 | iron coordination entity transport (GO:1901678) | 3.95787657 |
| 68 | glycerol metabolic process (GO:0006071) | 3.94810419 |
| 69 | oxidative demethylation (GO:0070989) | 3.92988688 |
| 70 | positive regulation of meiosis (GO:0045836) | 3.86383852 |
| 71 | short-term memory (GO:0007614) | 3.83399036 |
| 72 | ribonucleoprotein complex disassembly (GO:0032988) | 3.79288816 |
| 73 | neuron development (GO:0048666) | 3.76648152 |
| 74 | * response to light stimulus (GO:0009416) | 3.74246085 |
| 75 | vitamin transmembrane transport (GO:0035461) | 3.74236899 |
| 76 | estrogen biosynthetic process (GO:0006703) | 3.73456290 |
| 77 | retina homeostasis (GO:0001895) | 3.72352746 |
| 78 | cellular glucuronidation (GO:0052695) | 3.71035435 |
| 79 | positive regulation of meiotic cell cycle (GO:0051446) | 3.65733595 |
| 80 | regulation of penile erection (GO:0060405) | 3.63122772 |
| 81 | paraxial mesoderm development (GO:0048339) | 3.62526623 |
| 82 | behavioral response to ethanol (GO:0048149) | 3.61432407 |
| 83 | alditol metabolic process (GO:0019400) | 3.61289229 |
| 84 | glucuronate metabolic process (GO:0019585) | 3.59238081 |
| 85 | uronic acid metabolic process (GO:0006063) | 3.59238081 |
| 86 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.58509381 |
| 87 | bile acid metabolic process (GO:0008206) | 3.57943305 |
| 88 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.57133467 |
| 89 | chemosensory behavior (GO:0007635) | 3.53344160 |
| 90 | protein localization to synapse (GO:0035418) | 3.51847317 |
| 91 | urate metabolic process (GO:0046415) | 3.46862136 |
| 92 | amino-acid betaine metabolic process (GO:0006577) | 3.44448210 |
| 93 | glyoxylate metabolic process (GO:0046487) | 3.42696850 |
| 94 | nodal signaling pathway (GO:0038092) | 3.41804898 |
| 95 | organelle disassembly (GO:1903008) | 3.41427128 |
| 96 | cellular biogenic amine catabolic process (GO:0042402) | 3.40721667 |
| 97 | amine catabolic process (GO:0009310) | 3.40721667 |
| 98 | DNA deamination (GO:0045006) | 3.39392215 |
| 99 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.39373815 |
| 100 | aspartate family amino acid catabolic process (GO:0009068) | 3.37676013 |
| 101 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.36735282 |
| 102 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.36735282 |
| 103 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.34169799 |
| 104 | tryptophan metabolic process (GO:0006568) | 3.33109380 |
| 105 | meiotic chromosome segregation (GO:0045132) | 3.31340072 |
| 106 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.27679560 |
| 107 | toxin metabolic process (GO:0009404) | 3.26683182 |
| 108 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.24646413 |
| 109 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.22166232 |
| 110 | response to histamine (GO:0034776) | 3.21376839 |
| 111 | pantothenate metabolic process (GO:0015939) | 3.21186526 |
| 112 | lysine metabolic process (GO:0006553) | 3.21094710 |
| 113 | lysine catabolic process (GO:0006554) | 3.21094710 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 3.15762496 |
| 115 | positive regulation of neurotransmitter transport (GO:0051590) | 3.13421377 |
| 116 | notochord development (GO:0030903) | 3.13029413 |
| 117 | response to mercury ion (GO:0046689) | 3.11181130 |
| 118 | axoneme assembly (GO:0035082) | 3.09883048 |
| 119 | kynurenine metabolic process (GO:0070189) | 3.07676281 |
| 120 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.04359577 |
| 121 | L-methionine salvage (GO:0071267) | 3.02460759 |
| 122 | L-methionine biosynthetic process (GO:0071265) | 3.02460759 |
| 123 | amino acid salvage (GO:0043102) | 3.02460759 |
| 124 | membrane hyperpolarization (GO:0060081) | 3.01370030 |
| 125 | sulfur compound transport (GO:0072348) | 3.01081450 |
| 126 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.00338007 |
| 127 | S-adenosylmethionine metabolic process (GO:0046500) | 2.99622758 |
| 128 | xenobiotic catabolic process (GO:0042178) | 2.97003128 |
| 129 | protein heterotetramerization (GO:0051290) | 2.95228103 |
| 130 | somite rostral/caudal axis specification (GO:0032525) | 2.95103556 |
| 131 | serotonin receptor signaling pathway (GO:0007210) | 2.94287969 |
| 132 | bile acid biosynthetic process (GO:0006699) | 2.92722556 |
| 133 | tachykinin receptor signaling pathway (GO:0007217) | 2.90762704 |
| 134 | serine family amino acid catabolic process (GO:0009071) | 2.87593091 |
| 135 | alkaloid metabolic process (GO:0009820) | 2.84382671 |
| 136 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.84279080 |
| 137 | alpha-amino acid catabolic process (GO:1901606) | 2.84196504 |
| 138 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.84022246 |
| 139 | benzene-containing compound metabolic process (GO:0042537) | 2.83082320 |
| 140 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.82966740 |
| 141 | response to nitrosative stress (GO:0051409) | 2.82629235 |
| 142 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.82201389 |
| 143 | phenylpropanoid metabolic process (GO:0009698) | 2.81839712 |
| 144 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.81052836 |
| 145 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.79907712 |
| 146 | cofactor transport (GO:0051181) | 2.79073011 |
| 147 | drug transmembrane transport (GO:0006855) | 2.77857905 |
| 148 | behavioral response to nicotine (GO:0035095) | 2.77528722 |
| 149 | retinoid metabolic process (GO:0001523) | 2.77497178 |
| 150 | positive regulation of fatty acid oxidation (GO:0046321) | 2.75276338 |
| 151 | SMAD protein complex assembly (GO:0007183) | 2.73351973 |
| 152 | ketone body metabolic process (GO:1902224) | 2.72467289 |
| 153 | icosanoid secretion (GO:0032309) | 2.72203140 |
| 154 | arachidonic acid secretion (GO:0050482) | 2.72203140 |
| 155 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.72195169 |
| 156 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.70556955 |
| 157 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.70466258 |
| 158 | indole-containing compound metabolic process (GO:0042430) | 2.70367384 |
| 159 | glycine metabolic process (GO:0006544) | 2.69739928 |
| 160 | L-fucose metabolic process (GO:0042354) | 2.68225576 |
| 161 | negative regulation of cation channel activity (GO:2001258) | 2.64280907 |
| 162 | behavioral response to cocaine (GO:0048148) | 2.63335575 |
| 163 | righting reflex (GO:0060013) | 2.62443448 |
| 164 | synaptic transmission, dopaminergic (GO:0001963) | 2.62189181 |
| 165 | * response to radiation (GO:0009314) | 2.61899803 |
| 166 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.60968627 |
| 167 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.59343738 |
| 168 | diterpenoid metabolic process (GO:0016101) | 2.56559568 |
| 169 | sensory perception of smell (GO:0007608) | 2.56465202 |
| 170 | phospholipid translocation (GO:0045332) | 2.56313321 |
| 171 | lipid translocation (GO:0034204) | 2.56313321 |
| 172 | retinol metabolic process (GO:0042572) | 2.56216312 |
| 173 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.54973246 |
| 174 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.54973246 |
| 175 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.52317320 |
| 176 | dopamine receptor signaling pathway (GO:0007212) | 2.52024321 |
| 177 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.39806264 |
| 178 | positive regulation of cyclase activity (GO:0031281) | 2.39309307 |
| 179 | * cellular response to abiotic stimulus (GO:0071214) | 2.37653641 |
| 180 | positive regulation of membrane potential (GO:0045838) | 2.37225364 |
| 181 | regulation of dopamine metabolic process (GO:0042053) | 2.36397689 |
| 182 | regulation of catecholamine metabolic process (GO:0042069) | 2.36397689 |
| 183 | regulation of neurotransmitter uptake (GO:0051580) | 2.35757672 |
| 184 | terpenoid metabolic process (GO:0006721) | 2.32983854 |
| 185 | post-embryonic morphogenesis (GO:0009886) | 2.30530672 |
| 186 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.1711360 |
| 187 | * rhodopsin mediated signaling pathway (GO:0016056) | 17.7392513 |
| 188 | retinal cone cell development (GO:0046549) | 15.1751226 |
| 189 | photoreceptor cell development (GO:0042461) | 12.5052044 |
| 190 | photoreceptor cell maintenance (GO:0045494) | 12.3671424 |
| 191 | eye photoreceptor cell development (GO:0042462) | 11.9452363 |
| 192 | sphingosine metabolic process (GO:0006670) | 11.2560626 |
| 193 | detection of light stimulus involved in sensory perception (GO:0050962) | 10.8524082 |
| 194 | detection of light stimulus involved in visual perception (GO:0050908) | 10.8524082 |
| 195 | * phototransduction (GO:0007602) | 10.4248387 |
| 196 | GMP metabolic process (GO:0046037) | 10.4000442 |
| 197 | * phototransduction, visible light (GO:0007603) | 10.2428754 |
| 198 | diol metabolic process (GO:0034311) | 10.2381253 |
| 199 | positive regulation of guanylate cyclase activity (GO:0031284) | 10.0451961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.83472277 |
| 2 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 3.39795701 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.38654070 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.16879691 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.92199196 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.74764021 |
| 7 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.59545133 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.57247664 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.14672450 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12074638 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.10984167 |
| 12 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.06407173 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.04952460 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.04353829 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95492654 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88176091 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87079001 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85317466 |
| 19 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.82771734 |
| 20 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.82771734 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78192640 |
| 22 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75385085 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74480658 |
| 24 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.74350846 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.70847382 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.69687078 |
| 27 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67586658 |
| 28 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.66639654 |
| 29 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.65866314 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64893914 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64365926 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63777417 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62950138 |
| 34 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.61809787 |
| 35 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.61266046 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.58744102 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.58744102 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56996207 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56949007 |
| 40 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56523662 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54015041 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53749984 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.52318150 |
| 44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52011223 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50926289 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.49512540 |
| 47 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49236491 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.49169713 |
| 49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47391984 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47239042 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46315925 |
| 52 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.45955440 |
| 53 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.43726401 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.43074639 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.43074639 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.42306525 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.41640044 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.41412674 |
| 59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40946753 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39761112 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39405369 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39394716 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39394716 |
| 64 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.38149943 |
| 65 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37681837 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35946743 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35935506 |
| 68 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.35751379 |
| 69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35599765 |
| 70 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.35455799 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.33900191 |
| 72 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33800472 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33664999 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32191478 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31223070 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29916548 |
| 77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29284364 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29185239 |
| 79 | TBL1_22424771_ChIP-Seq_293T_Human | 1.29153543 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28018298 |
| 81 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.27895947 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.27223889 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26559172 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.25783882 |
| 85 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.24571841 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24498431 |
| 87 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.23228166 |
| 88 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.21901280 |
| 89 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21765568 |
| 90 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21640822 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21150729 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21133986 |
| 93 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20893914 |
| 94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20725265 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.20601487 |
| 96 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20026675 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19529462 |
| 98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.19410562 |
| 99 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17153978 |
| 100 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14457815 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13451487 |
| 102 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13105237 |
| 103 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.12749997 |
| 104 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12293226 |
| 105 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12201372 |
| 106 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12114534 |
| 107 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.11926214 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11848294 |
| 109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11318353 |
| 110 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11306572 |
| 111 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11121107 |
| 112 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09970276 |
| 113 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.09875112 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.09798702 |
| 115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09636977 |
| 116 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.09625484 |
| 117 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09112959 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.08953464 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07195875 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07082972 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07082972 |
| 122 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07023648 |
| 123 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06994481 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06874255 |
| 125 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.06552112 |
| 126 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05956414 |
| 127 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05802148 |
| 128 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05646876 |
| 129 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.05623201 |
| 130 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05530325 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.05422478 |
| 132 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05063920 |
| 133 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04752149 |
| 134 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.04461051 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04016362 |
| 136 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03638313 |
| 137 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02850847 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02579083 |
| 139 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02311384 |
| 140 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02163558 |
| 141 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01725837 |
| 142 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00924954 |
| 143 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00846587 |
| 144 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00824686 |
| 145 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00536808 |
| 146 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99416782 |
| 147 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99072406 |
| 148 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98987837 |
| 149 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98332688 |
| 150 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98308578 |
| 151 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.97815224 |
| 152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.97727334 |
| 153 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97612257 |
| 154 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97396001 |
| 155 | EWS_26573619_Chip-Seq_HEK293_Human | 0.97309358 |
| 156 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96996137 |
| 157 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95578447 |
| 158 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94792269 |
| 159 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94128829 |
| 160 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93959335 |
| 161 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93381848 |
| 162 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92476371 |
| 163 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91343722 |
| 164 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90973658 |
| 165 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90244515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 9.71847115 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 7.69613162 |
| 3 | MP0005253_abnormal_eye_physiology | 6.92173637 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 6.45553703 |
| 5 | MP0003136_yellow_coat_color | 5.93888898 |
| 6 | MP0005171_absent_coat_pigmentation | 4.99501669 |
| 7 | MP0003950_abnormal_plasma_membrane | 4.12255560 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 4.02793553 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.98921793 |
| 10 | MP0005195_abnormal_posterior_eye | 3.88821462 |
| 11 | MP0003195_calcinosis | 3.54453300 |
| 12 | MP0001324_abnormal_eye_pigmentation | 3.49796271 |
| 13 | MP0005391_vision/eye_phenotype | 3.34213376 |
| 14 | MP0005365_abnormal_bile_salt | 3.27793230 |
| 15 | MP0002638_abnormal_pupillary_reflex | 3.26965868 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.76383930 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.69761241 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.68292491 |
| 19 | MP0002090_abnormal_vision | 2.67213548 |
| 20 | MP0005670_abnormal_white_adipose | 2.64627844 |
| 21 | MP0003879_abnormal_hair_cell | 2.63692810 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.59381536 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.58905170 |
| 24 | MP0002229_neurodegeneration | 2.57365440 |
| 25 | MP0001764_abnormal_homeostasis | 2.16799400 |
| 26 | MP0005360_urolithiasis | 2.10561956 |
| 27 | MP0003252_abnormal_bile_duct | 2.10085985 |
| 28 | MP0004147_increased_porphyrin_level | 2.03500133 |
| 29 | MP0002752_abnormal_somatic_nervous | 2.00431348 |
| 30 | MP0003011_delayed_dark_adaptation | 10.7447602 |
| 31 | MP0002938_white_spotting | 1.92404237 |
| 32 | MP0004381_abnormal_hair_follicle | 1.75348039 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.73999361 |
| 34 | MP0002168_other_aberrant_phenotype | 1.63875418 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.42220439 |
| 36 | MP0000749_muscle_degeneration | 1.41250557 |
| 37 | MP0002882_abnormal_neuron_morphology | 1.40819535 |
| 38 | MP0008872_abnormal_physiological_respon | 1.36950173 |
| 39 | MP0001984_abnormal_olfaction | 1.32694373 |
| 40 | MP0005395_other_phenotype | 1.31204520 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.30168722 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.25717304 |
| 43 | MP0002653_abnormal_ependyma_morphology | 1.18319377 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.14903471 |
| 45 | MP0005332_abnormal_amino_acid | 1.12081268 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.11243888 |
| 47 | MP0002254_reproductive_system_inflammat | 1.11208472 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.10006204 |
| 49 | MP0000427_abnormal_hair_cycle | 1.09143435 |
| 50 | MP0002160_abnormal_reproductive_system | 1.09054891 |
| 51 | MP0002095_abnormal_skin_pigmentation | 1.08848022 |
| 52 | MP0005197_abnormal_uvea_morphology | 1.07988419 |
| 53 | MP0001486_abnormal_startle_reflex | 0.97275458 |
| 54 | MP0004885_abnormal_endolymph | 0.95294460 |
| 55 | MP0002163_abnormal_gland_morphology | 0.93913082 |
| 56 | MP0005394_taste/olfaction_phenotype | 0.91325175 |
| 57 | MP0005499_abnormal_olfactory_system | 0.91325175 |
| 58 | MP0003718_maternal_effect | 0.89731269 |
| 59 | MP0002332_abnormal_exercise_endurance | 0.88678470 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 0.86273909 |
| 61 | MP0002735_abnormal_chemical_nociception | 0.85208355 |
| 62 | MP0004270_analgesia | 0.83812830 |
| 63 | MP0002272_abnormal_nervous_system | 0.83078755 |
| 64 | MP0008789_abnormal_olfactory_epithelium | 0.82778105 |
| 65 | MP0003137_abnormal_impulse_conducting | 0.81548252 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 0.81143062 |
| 67 | MP0005174_abnormal_tail_pigmentation | 0.79573045 |
| 68 | MP0004233_abnormal_muscle_weight | 0.79368011 |
| 69 | MP0003634_abnormal_glial_cell | 0.77858727 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.77574748 |
| 71 | MP0005187_abnormal_penis_morphology | 0.76945799 |
| 72 | MP0002127_abnormal_cardiovascular_syste | 0.76711051 |
| 73 | MP0009764_decreased_sensitivity_to | 0.75579033 |
| 74 | MP0005410_abnormal_fertilization | 0.74300254 |
| 75 | MP0002075_abnormal_coat/hair_pigmentati | 0.74123518 |
| 76 | MP0003880_abnormal_central_pattern | 0.74064130 |
| 77 | MP0003868_abnormal_feces_composition | 0.73366659 |
| 78 | MP0002102_abnormal_ear_morphology | 0.70940194 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 0.68853155 |
| 80 | MP0005389_reproductive_system_phenotype | 0.68442806 |
| 81 | MP0006276_abnormal_autonomic_nervous | 0.68248737 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.66611238 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.66055304 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.65729844 |
| 85 | MP0003878_abnormal_ear_physiology | 0.65729844 |
| 86 | MP0002269_muscular_atrophy | 0.63019884 |
| 87 | MP0009046_muscle_twitch | 0.62332887 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.62227274 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.61626690 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 0.61485975 |
| 91 | MP0005330_cardiomyopathy | 0.60376556 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.59473640 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.58971235 |
| 94 | MP0001286_abnormal_eye_development | 0.57680456 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.55850506 |
| 96 | MP0002736_abnormal_nociception_after | 0.55659365 |
| 97 | MP0002064_seizures | 0.55559354 |
| 98 | MP0005266_abnormal_metabolism | 0.53912262 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.50262207 |
| 100 | MP0002971_abnormal_brown_adipose | 0.50198184 |
| 101 | MP0003635_abnormal_synaptic_transmissio | 0.49777451 |
| 102 | MP0005220_abnormal_exocrine_pancreas | 0.49310248 |
| 103 | MP0000026_abnormal_inner_ear | 0.48915612 |
| 104 | MP0002572_abnormal_emotion/affect_behav | 0.46981488 |
| 105 | MP0005376_homeostasis/metabolism_phenot | 0.46337975 |
| 106 | MP0002751_abnormal_autonomic_nervous | 0.44947320 |
| 107 | MP0004859_abnormal_synaptic_plasticity | 0.44579546 |
| 108 | MP0009745_abnormal_behavioral_response | 0.44335042 |
| 109 | MP0001186_pigmentation_phenotype | 0.44193413 |
| 110 | MP0005448_abnormal_energy_balance | 0.43768238 |
| 111 | MP0004742_abnormal_vestibular_system | 0.43655218 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.43466369 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.43201636 |
| 114 | MP0005535_abnormal_body_temperature | 0.42599716 |
| 115 | MP0002063_abnormal_learning/memory/cond | 0.42332631 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.41044189 |
| 117 | MP0000465_gastrointestinal_hemorrhage | 0.40454666 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.40136914 |
| 119 | MP0000383_abnormal_hair_follicle | 0.40051888 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.40042101 |
| 121 | MP0001968_abnormal_touch/_nociception | 0.38646716 |
| 122 | MP0001905_abnormal_dopamine_level | 0.37254496 |
| 123 | MP0001188_hyperpigmentation | 0.36842588 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.36203374 |
| 125 | MP0003045_fibrosis | 0.34692245 |
| 126 | MP0004142_abnormal_muscle_tone | 0.34618896 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.32873500 |
| 128 | MP0005646_abnormal_pituitary_gland | 0.30715488 |
| 129 | MP0004043_abnormal_pH_regulation | 0.30329241 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.30315162 |
| 131 | MP0004924_abnormal_behavior | 0.29089566 |
| 132 | MP0005386_behavior/neurological_phenoty | 0.29089566 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.26949936 |
| 134 | MP0004085_abnormal_heartbeat | 0.26817810 |
| 135 | MP0005409_darkened_coat_color | 0.25323407 |
| 136 | MP0001661_extended_life_span | 0.25317810 |
| 137 | MP0002184_abnormal_innervation | 0.24883064 |
| 138 | MP0002557_abnormal_social/conspecific_i | 0.24864318 |
| 139 | MP0008569_lethality_at_weaning | 0.24863665 |
| 140 | MP0005310_abnormal_salivary_gland | 0.24361949 |
| 141 | MP0003890_abnormal_embryonic-extraembry | 0.23717497 |
| 142 | MP0008004_abnormal_stomach_pH | 0.23399909 |
| 143 | MP0003646_muscle_fatigue | 0.23043469 |
| 144 | MP0005620_abnormal_muscle_contractility | 0.22969708 |
| 145 | MP0002066_abnormal_motor_capabilities/c | 0.22272573 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.21420228 |
| 147 | MP0002152_abnormal_brain_morphology | 0.20338494 |
| 148 | MP0002697_abnormal_eye_size | 0.19964769 |
| 149 | MP0008058_abnormal_DNA_repair | 0.19500869 |
| 150 | MP0001501_abnormal_sleep_pattern | 0.18638336 |
| 151 | MP0005193_abnormal_anterior_eye | 0.17866738 |
| 152 | MP0000778_abnormal_nervous_system | 0.17186445 |
| 153 | MP0001970_abnormal_pain_threshold | 0.16545468 |
| 154 | MP0003787_abnormal_imprinting | 0.15971999 |
| 155 | MP0002928_abnormal_bile_duct | 0.15904151 |
| 156 | MP0004811_abnormal_neuron_physiology | 0.13346849 |
| 157 | MP0005076_abnormal_cell_differentiation | 0.12177073 |
| 158 | MP0008995_early_reproductive_senescence | 0.10611234 |
| 159 | MP0003632_abnormal_nervous_system | 0.10399703 |
| 160 | MP0003633_abnormal_nervous_system | 0.09675777 |
| 161 | MP0001177_atelectasis | 0.09077437 |
| 162 | MP0000751_myopathy | 0.08388005 |
| 163 | MP0004133_heterotaxia | 0.08022862 |
| 164 | MP0000001_mammalian_phenotype | 0.07758577 |
| 165 | MP0001440_abnormal_grooming_behavior | 0.07149722 |
| 166 | MP0003698_abnormal_male_reproductive | 0.07090189 |
| 167 | MP0003638_abnormal_response/metabolism_ | 0.06430424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pigmentary retinal degeneration (HP:0001146) | 9.27944745 |
| 2 | Chorioretinal atrophy (HP:0000533) | 9.00178466 |
| 3 | Central scotoma (HP:0000603) | 7.99951960 |
| 4 | Attenuation of retinal blood vessels (HP:0007843) | 7.89257596 |
| 5 | Pendular nystagmus (HP:0012043) | 7.73226254 |
| 6 | Dyschromatopsia (HP:0007641) | 7.70757079 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 7.36648838 |
| 8 | Amelogenesis imperfecta (HP:0000705) | 7.26367799 |
| 9 | Scotoma (HP:0000575) | 7.19626383 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 6.68165496 |
| 11 | Focal motor seizures (HP:0011153) | 6.45557231 |
| 12 | Decreased central vision (HP:0007663) | 6.44016069 |
| 13 | * Photophobia (HP:0000613) | 5.56612473 |
| 14 | * Type II diabetes mellitus (HP:0005978) | 5.53920385 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.18488038 |
| 16 | Acanthocytosis (HP:0001927) | 5.12660711 |
| 17 | Keratoconus (HP:0000563) | 5.10500119 |
| 18 | Increased corneal curvature (HP:0100692) | 5.10500119 |
| 19 | Parakeratosis (HP:0001036) | 5.03389570 |
| 20 | Vitreoretinal degeneration (HP:0000655) | 4.98202006 |
| 21 | Macular degeneration (HP:0000608) | 4.96678459 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.88318617 |
| 23 | Cone-rod dystrophy (HP:0000548) | 4.82608283 |
| 24 | Severe visual impairment (HP:0001141) | 4.57868182 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.53357938 |
| 26 | Choroideremia (HP:0001139) | 4.39911383 |
| 27 | * Retinitis pigmentosa (HP:0000510) | 4.33388783 |
| 28 | Constricted visual fields (HP:0001133) | 4.27365633 |
| 29 | Posterior subcapsular cataract (HP:0007787) | 4.17317180 |
| 30 | Aplastic anemia (HP:0001915) | 3.90125783 |
| 31 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.63420224 |
| 32 | Abnormality of the renal cortex (HP:0011035) | 3.40524179 |
| 33 | Dialeptic seizures (HP:0011146) | 3.35030866 |
| 34 | Colon cancer (HP:0003003) | 3.32410482 |
| 35 | Progressive visual loss (HP:0000529) | 3.11041340 |
| 36 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.09760650 |
| 37 | Rectal prolapse (HP:0002035) | 3.08856314 |
| 38 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.05985330 |
| 39 | Facial shape deformation (HP:0011334) | 3.05870058 |
| 40 | Potter facies (HP:0002009) | 3.05870058 |
| 41 | Enlarged kidneys (HP:0000105) | 2.97886150 |
| 42 | Hyperglycinuria (HP:0003108) | 2.90665167 |
| 43 | Retinal atrophy (HP:0001105) | 2.86360231 |
| 44 | Proximal amyotrophy (HP:0007126) | 2.82768142 |
| 45 | Poikilocytosis (HP:0004447) | 2.79019720 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.76739525 |
| 47 | Optic disc pallor (HP:0000543) | 2.73930141 |
| 48 | Erythroderma (HP:0001019) | 2.72373461 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.63039306 |
| 50 | Hydroxyprolinuria (HP:0003080) | 2.62732409 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.62732409 |
| 52 | Gait imbalance (HP:0002141) | 2.60811425 |
| 53 | Congenital sensorineural hearing impairment (HP:0008527) | 2.59367845 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.59283192 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56464789 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.55959737 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55959737 |
| 58 | Focal seizures (HP:0007359) | 2.53867008 |
| 59 | Subcapsular cataract (HP:0000523) | 2.50527458 |
| 60 | * Wide nasal bridge (HP:0000431) | 2.46202364 |
| 61 | Hypobetalipoproteinemia (HP:0003563) | 2.45507051 |
| 62 | Tubular atrophy (HP:0000092) | 2.45118040 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41308765 |
| 64 | Progressive inability to walk (HP:0002505) | 2.34426709 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.31162853 |
| 66 | Decreased circulating renin level (HP:0003351) | 2.30599647 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.30252861 |
| 68 | Opisthotonus (HP:0002179) | 2.29570446 |
| 69 | Hypokalemia (HP:0002900) | 2.27487637 |
| 70 | Hematochezia (HP:0002573) | 2.26148492 |
| 71 | Difficulty walking (HP:0002355) | 2.23562556 |
| 72 | Tubulointerstitial fibrosis (HP:0005576) | 2.21633795 |
| 73 | Ulnar claw (HP:0001178) | 2.17347766 |
| 74 | Abnormal albumin level (HP:0012116) | 2.14505111 |
| 75 | Hypoalbuminemia (HP:0003073) | 2.14505111 |
| 76 | Inability to walk (HP:0002540) | 2.13163995 |
| 77 | Epidermoid cyst (HP:0200040) | 2.11041226 |
| 78 | Overlapping toe (HP:0001845) | 2.10991748 |
| 79 | Abnormality of alanine metabolism (HP:0010916) | 2.05037415 |
| 80 | Hyperalaninemia (HP:0003348) | 2.05037415 |
| 81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.05037415 |
| 82 | Hyperglycinemia (HP:0002154) | 2.00058675 |
| 83 | Congenital stationary night blindness (HP:0007642) | 15.2042315 |
| 84 | Bony spicule pigmentary retinopathy (HP:0007737) | 12.0278503 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.6657997 |
| 86 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.3891309 |
| 87 | Fair hair (HP:0002286) | 1.98878526 |
| 88 | Chronic diarrhea (HP:0002028) | 1.97864332 |
| 89 | Type II lissencephaly (HP:0007260) | 1.95677424 |
| 90 | Poor coordination (HP:0002370) | 1.94513665 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 1.94366686 |
| 92 | Glycosuria (HP:0003076) | 1.94366686 |
| 93 | Abnormality of potassium homeostasis (HP:0011042) | 1.90027714 |
| 94 | Abnormal glycosylation (HP:0012345) | 1.89859545 |
| 95 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.89859545 |
| 96 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.89859545 |
| 97 | Abnormal protein glycosylation (HP:0012346) | 1.89859545 |
| 98 | Stomach cancer (HP:0012126) | 1.89020281 |
| 99 | Portal hypertension (HP:0001409) | 1.84661460 |
| 100 | Dehydration (HP:0001944) | 1.84405171 |
| 101 | True hermaphroditism (HP:0010459) | 1.83970612 |
| 102 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.82123919 |
| 103 | Abnormal pancreas size (HP:0012094) | 1.81919791 |
| 104 | Vaginal atresia (HP:0000148) | 1.81497609 |
| 105 | Abnormality of the vocal cords (HP:0008777) | 1.80784569 |
| 106 | Tubulointerstitial abnormality (HP:0001969) | 1.80215089 |
| 107 | Vertebral arch anomaly (HP:0008438) | 1.78443373 |
| 108 | Gangrene (HP:0100758) | 1.75882523 |
| 109 | Spontaneous hematomas (HP:0007420) | 1.75399743 |
| 110 | Chromsome breakage (HP:0040012) | 1.74308466 |
| 111 | Genital tract atresia (HP:0001827) | 1.74239283 |
| 112 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.72904129 |
| 113 | Hypoplastic iliac wings (HP:0002866) | 1.71818807 |
| 114 | Bile duct proliferation (HP:0001408) | 1.70423227 |
| 115 | Abnormal biliary tract physiology (HP:0012439) | 1.70423227 |
| 116 | Ileus (HP:0002595) | 1.68855134 |
| 117 | Abnormal drinking behavior (HP:0030082) | 1.68264381 |
| 118 | Polydipsia (HP:0001959) | 1.68264381 |
| 119 | Ketosis (HP:0001946) | 1.65323778 |
| 120 | Xanthomatosis (HP:0000991) | 1.64419646 |
| 121 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.64252908 |
| 122 | Conjunctival telangiectasia (HP:0000524) | 1.63833678 |
| 123 | Abnormality of serum amino acid levels (HP:0003112) | 1.63468902 |
| 124 | Abnormality of the hepatic vasculature (HP:0006707) | 1.62311439 |
| 125 | * Optic atrophy (HP:0000648) | 1.60165037 |
| 126 | Pancreatic fibrosis (HP:0100732) | 1.57718739 |
| 127 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.54371810 |
| 128 | Horizontal nystagmus (HP:0000666) | 1.50233279 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.49408928 |
| 130 | Polar cataract (HP:0010696) | 1.34754607 |
| 131 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.31487991 |
| 132 | Hypoplasia of the fovea (HP:0007750) | 1.31487991 |
| 133 | Abnormality of the fovea (HP:0000493) | 1.31292615 |
| 134 | Pancreatic cysts (HP:0001737) | 1.30140706 |
| 135 | Astigmatism (HP:0000483) | 1.27741097 |
| 136 | Severe Myopia (HP:0011003) | 1.26306246 |
| 137 | Recurrent sinusitis (HP:0011108) | 1.26164865 |
| 138 | Cystic liver disease (HP:0006706) | 1.22971309 |
| 139 | Dysdiadochokinesis (HP:0002075) | 1.20912502 |
| 140 | Febrile seizures (HP:0002373) | 1.19534265 |
| 141 | Epileptic encephalopathy (HP:0200134) | 1.16184017 |
| 142 | Retinal detachment (HP:0000541) | 1.12327975 |
| 143 | Chorioretinal coloboma (HP:0000567) | 1.03898310 |
| 144 | Partial agenesis of the corpus callosum (HP:0001338) | 1.03454516 |
| 145 | Broad foot (HP:0001769) | 1.03252722 |
| 146 | Specific learning disability (HP:0001328) | 1.03220463 |
| 147 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.03200654 |
| 148 | Abnormality of midbrain morphology (HP:0002418) | 1.01836555 |
| 149 | Molar tooth sign on MRI (HP:0002419) | 1.01836555 |
| 150 | Left ventricular hypertrophy (HP:0001712) | 1.00169996 |
| 151 | Asthma (HP:0002099) | 1.00096027 |
| 152 | Decreased testicular size (HP:0008734) | 0.96621949 |
| 153 | Cerebellar dysplasia (HP:0007033) | 0.94732283 |
| 154 | Sclerocornea (HP:0000647) | 0.93332643 |
| 155 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.92910500 |
| 156 | Nephronophthisis (HP:0000090) | 0.91917487 |
| 157 | Abnormality of the renal medulla (HP:0100957) | 0.88532014 |
| 158 | Congenital hepatic fibrosis (HP:0002612) | 0.85386010 |
| 159 | Progressive cerebellar ataxia (HP:0002073) | 0.85096855 |
| 160 | Abnormality of dental color (HP:0011073) | 0.84557602 |
| 161 | Hypermetropia (HP:0000540) | 0.82636437 |
| 162 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.81843485 |
| 163 | Anencephaly (HP:0002323) | 0.81429319 |
| 164 | Postaxial hand polydactyly (HP:0001162) | 0.79965317 |
| 165 | Chronic hepatic failure (HP:0100626) | 0.79518917 |
| 166 | Furrowed tongue (HP:0000221) | 0.77471103 |
| 167 | Truncal ataxia (HP:0002078) | 0.74990494 |
| 168 | Dental crowding (HP:0000678) | 0.74578982 |
| 169 | Osteomalacia (HP:0002749) | 0.74398765 |
| 170 | Lymphopenia (HP:0001888) | 0.73802567 |
| 171 | Septo-optic dysplasia (HP:0100842) | 0.71557111 |
| 172 | Hypodontia (HP:0000668) | 0.70135863 |
| 173 | Short foot (HP:0001773) | 0.68770913 |
| 174 | Multicystic kidney dysplasia (HP:0000003) | 0.67313011 |
| 175 | Visual hallucinations (HP:0002367) | 0.67094799 |
| 176 | Postaxial foot polydactyly (HP:0001830) | 0.66857295 |
| 177 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.66799236 |
| 178 | Nephrotic syndrome (HP:0000100) | 0.65674056 |
| 179 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.65622706 |
| 180 | Male pseudohermaphroditism (HP:0000037) | 0.65326134 |
| 181 | Tubulointerstitial nephritis (HP:0001970) | 0.63730592 |
| 182 | Broad-based gait (HP:0002136) | 0.62890507 |
| 183 | Preaxial hand polydactyly (HP:0001177) | 0.61466023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 7.79022541 |
| 2 | STK38L | 6.71163002 |
| 3 | LATS2 | 5.39749569 |
| 4 | ZAK | 3.40467357 |
| 5 | ACVR1B | 3.26689820 |
| 6 | IRAK2 | 2.77235895 |
| 7 | PINK1 | 2.69917830 |
| 8 | NLK | 2.22850281 |
| 9 | BMPR1B | 2.18865682 |
| 10 | STK3 | 2.12847056 |
| 11 | GRK1 | 10.5014031 |
| 12 | MAP2K2 | 1.89381185 |
| 13 | SIK2 | 1.76506104 |
| 14 | TAOK3 | 1.71549482 |
| 15 | INSRR | 1.67409686 |
| 16 | MELK | 1.54873043 |
| 17 | MKNK2 | 1.48565391 |
| 18 | ADRBK1 | 1.46128300 |
| 19 | CAMK1G | 1.36958213 |
| 20 | MAPK7 | 1.36767601 |
| 21 | ADRBK2 | 1.32986176 |
| 22 | LMTK2 | 1.32921762 |
| 23 | CASK | 1.25146927 |
| 24 | CCNB1 | 1.22842095 |
| 25 | MAPK12 | 1.16445673 |
| 26 | CDK3 | 1.15178774 |
| 27 | HIPK2 | 1.11741473 |
| 28 | EIF2AK3 | 1.11049130 |
| 29 | BRD4 | 1.08244678 |
| 30 | PIK3CG | 1.07704554 |
| 31 | MAP3K10 | 1.07114535 |
| 32 | TAF1 | 1.06704731 |
| 33 | CAMK1D | 1.04014430 |
| 34 | SGK223 | 1.03023737 |
| 35 | SGK494 | 1.03023737 |
| 36 | MAP4K2 | 1.02800527 |
| 37 | NEK6 | 1.02713505 |
| 38 | MAP3K2 | 0.99199359 |
| 39 | PNCK | 0.98656846 |
| 40 | STK38 | 0.96124559 |
| 41 | CSNK1D | 0.95417470 |
| 42 | CDK12 | 0.94256202 |
| 43 | AKT3 | 0.93831912 |
| 44 | MARK1 | 0.92029643 |
| 45 | PRKCZ | 0.90125458 |
| 46 | TGFBR1 | 0.88166459 |
| 47 | TNIK | 0.87552644 |
| 48 | RPS6KA4 | 0.87027018 |
| 49 | PAK6 | 0.85653566 |
| 50 | SGK2 | 0.84742320 |
| 51 | WNK3 | 0.84667000 |
| 52 | BRSK2 | 0.81133199 |
| 53 | TLK1 | 0.81064177 |
| 54 | OXSR1 | 0.80505075 |
| 55 | ERBB2 | 0.78336391 |
| 56 | FES | 0.78268501 |
| 57 | PKN1 | 0.77140676 |
| 58 | BLK | 0.75934752 |
| 59 | DAPK2 | 0.73834826 |
| 60 | PRKAA2 | 0.71749574 |
| 61 | PDPK1 | 0.69988770 |
| 62 | CAMK2D | 0.69982504 |
| 63 | WNK1 | 0.69894453 |
| 64 | CSNK1A1L | 0.69701425 |
| 65 | DYRK1A | 0.69007362 |
| 66 | PRPF4B | 0.68238109 |
| 67 | PRKCH | 0.68051879 |
| 68 | PRKCB | 0.64114911 |
| 69 | STK16 | 0.63820387 |
| 70 | YES1 | 0.63632627 |
| 71 | PRKD2 | 0.63358233 |
| 72 | SGK3 | 0.63143880 |
| 73 | NTRK3 | 0.61012946 |
| 74 | TTK | 0.60218412 |
| 75 | MKNK1 | 0.59730288 |
| 76 | MAP2K7 | 0.59432020 |
| 77 | CAMK1 | 0.58577542 |
| 78 | MST4 | 0.58286691 |
| 79 | MAP3K4 | 0.58043171 |
| 80 | GRK7 | 0.57108830 |
| 81 | NME1 | 0.56600849 |
| 82 | CAMKK1 | 0.56491768 |
| 83 | PRKAA1 | 0.56184043 |
| 84 | PRKACG | 0.55820763 |
| 85 | GRK5 | 0.55500744 |
| 86 | CAMK2A | 0.53549404 |
| 87 | PRKD3 | 0.52870342 |
| 88 | ICK | 0.52511309 |
| 89 | RPS6KA3 | 0.51292771 |
| 90 | TNK2 | 0.50326581 |
| 91 | NEK1 | 0.49855619 |
| 92 | PLK2 | 0.49113068 |
| 93 | SGK1 | 0.47557308 |
| 94 | NUAK1 | 0.47467444 |
| 95 | MAPK13 | 0.44958594 |
| 96 | PRKD1 | 0.42512655 |
| 97 | GSK3B | 0.41650215 |
| 98 | OBSCN | 0.41366944 |
| 99 | PHKG2 | 0.41272017 |
| 100 | PHKG1 | 0.41272017 |
| 101 | PLK1 | 0.40544141 |
| 102 | PRKDC | 0.40037849 |
| 103 | MAP2K1 | 0.40019717 |
| 104 | PRKCG | 0.38742756 |
| 105 | MAPK14 | 0.38574326 |
| 106 | PRKCE | 0.37988810 |
| 107 | PRKACA | 0.37014736 |
| 108 | NEK9 | 0.36758009 |
| 109 | PRKCI | 0.36004498 |
| 110 | PIK3CA | 0.35743971 |
| 111 | MYLK | 0.34874989 |
| 112 | TGFBR2 | 0.34644998 |
| 113 | CDK9 | 0.34295757 |
| 114 | MAPKAPK3 | 0.33564675 |
| 115 | CDK5 | 0.32782493 |
| 116 | STK11 | 0.32501235 |
| 117 | STK39 | 0.32409788 |
| 118 | MAPK10 | 0.31724893 |
| 119 | NEK2 | 0.31710108 |
| 120 | MAPK9 | 0.31509694 |
| 121 | PDK2 | 0.31352725 |
| 122 | CHEK2 | 0.31278158 |
| 123 | CAMK4 | 0.30853044 |
| 124 | TXK | 0.29302931 |
| 125 | PRKCA | 0.29284272 |
| 126 | RPS6KB1 | 0.28567707 |
| 127 | PLK3 | 0.28364988 |
| 128 | FRK | 0.28255607 |
| 129 | RPS6KA5 | 0.27881527 |
| 130 | CDK1 | 0.27767647 |
| 131 | NTRK2 | 0.26763898 |
| 132 | MUSK | 0.26635908 |
| 133 | AKT2 | 0.26434052 |
| 134 | WEE1 | 0.26388709 |
| 135 | LATS1 | 0.26310975 |
| 136 | CHUK | 0.26303828 |
| 137 | WNK4 | 0.24658665 |
| 138 | IRAK1 | 0.24227398 |
| 139 | CDC42BPA | 0.23418193 |
| 140 | PRKG2 | 0.22819126 |
| 141 | FER | 0.22452302 |
| 142 | PRKG1 | 0.22441062 |
| 143 | KSR2 | 0.21995788 |
| 144 | BCKDK | 0.21883079 |
| 145 | BMPR2 | 0.21331394 |
| 146 | VRK1 | 0.21038125 |
| 147 | IRAK3 | 0.20480693 |
| 148 | PIM1 | 0.18628888 |
| 149 | PAK3 | 0.16900718 |
| 150 | STK10 | 0.15475563 |
| 151 | EIF2AK2 | 0.15401755 |
| 152 | EPHA4 | 0.15273763 |
| 153 | PRKCQ | 0.15127109 |
| 154 | IKBKB | 0.14769653 |
| 155 | PTK2B | 0.14149468 |
| 156 | TRIM28 | 0.13873395 |
| 157 | CSNK1A1 | 0.13659320 |
| 158 | ABL1 | 0.13386720 |
| 159 | TEC | 0.11889273 |
| 160 | VRK2 | 0.10309741 |
| 161 | MAP3K12 | 0.09691519 |
| 162 | IGF1R | 0.08353791 |
| 163 | CDK19 | 0.08236290 |
| 164 | PRKACB | 0.07363532 |
| 165 | MAPK3 | 0.06317173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.41660231 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.80769751 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.72447746 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.62851080 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32770097 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.29663361 |
| 7 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.26209084 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.14370661 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05829683 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.04523464 |
| 11 | * Phototransduction_Homo sapiens_hsa04744 | 15.9988519 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93540313 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88953430 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88917926 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85501420 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73992726 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.65556273 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63037673 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.57382488 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.53260009 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46026097 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.41104844 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36740554 |
| 24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35578534 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.30617878 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27462379 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.23924793 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.22453662 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21416159 |
| 30 | GABAergic synapse_Homo sapiens_hsa04727 | 1.20501066 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17498187 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07514387 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05446900 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03899409 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98465026 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94967140 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94177636 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94065353 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93759484 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 0.93052440 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91379539 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90422618 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86894326 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86336881 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84650881 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83255281 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82901078 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82771219 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77888182 |
| 50 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77487965 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76424035 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76398269 |
| 53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71427716 |
| 54 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64744521 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.62743103 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62546649 |
| 57 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61764475 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59613545 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59045923 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.54883249 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54748780 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.54590779 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52913584 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46834599 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 0.45757117 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42928549 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42675142 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 0.40043009 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38083668 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37656436 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37474387 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37184172 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36687306 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36642300 |
| 75 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36320201 |
| 76 | Salivary secretion_Homo sapiens_hsa04970 | 0.35625394 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35088421 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35037513 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33647150 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32976330 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.31423702 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30690000 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30451754 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30388160 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30346281 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.30302423 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28255828 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27971301 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27217349 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.27028006 |
| 91 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26377169 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.25894436 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25537633 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25037252 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.24304550 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24247097 |
| 97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.23497660 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23310644 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23160642 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.22834767 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21453258 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21379758 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.21076861 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20475677 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19865513 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.19745126 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19684104 |
| 108 | Protein export_Homo sapiens_hsa03060 | 0.18595987 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18437052 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.18193812 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18059538 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.17389723 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.17051802 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16933887 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16789226 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16566689 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.16554886 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15958989 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.15934455 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15447256 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.15293321 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15121209 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.14649982 |
| 124 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.14383318 |
| 125 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.13047739 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12661897 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12061912 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11547482 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.11287311 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11269763 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.10327934 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10175236 |
| 133 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.09226797 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.09138822 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.09051419 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.08924176 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08312070 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08244893 |
| 139 | Mineral absorption_Homo sapiens_hsa04978 | 0.07835691 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07410998 |
| 141 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.06947856 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06723475 |
| 143 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.06179423 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06087386 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.05415327 |
| 146 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.05314967 |
| 147 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.05086961 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.04739255 |
| 149 | Tight junction_Homo sapiens_hsa04530 | 0.04539859 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04406950 |
| 151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04289679 |
| 152 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.03614187 |
| 153 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.03570833 |
| 154 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.03432534 |
| 155 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.03288739 |
| 156 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.03073917 |
| 157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.03060511 |
| 158 | Melanogenesis_Homo sapiens_hsa04916 | 0.02525640 |
| 159 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.02177978 |

